Prnewswire·2025-12-01 13:03Company Overview - Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments aimed at improving patient quality of life [2] - The company engages in early-stage pharmaceutical research and development, advancing drugs from bench to pre-clinical and clinical testing [2] Recent Developments - Robb Knie, the CEO of Hoth Therapeutics, is scheduled to present at the Noble Capital Markets 21st Annual Emerging Growth Equity Conference in Boca Raton, FL [1] - Hoth Therapeutics has been accepted into the NVIDIA Connect Program, which will enhance its AI and accelerated computing capabilities [6] Research Focus - The company is dedicated to developing breakthrough therapies for various conditions, including metabolic, dermatologic, and other diseases [7] - Hoth Therapeutics has launched a VA-backed study of a novel GDNF weight loss therapy targeting obesity and fatty liver disease [7]